U.S. Hospitality Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see RPC, Inc...

O'Reilly Automotive (ORLY) is back in focus after its first quarter 2026 report, which showed higher sales, net income and earnings per share, along with reaffirmed full year guidance and ongoing store expansion plans. See our latest analysis for O'Reilly Automotive. The earnings beat and reiterated outlook have coincided with improving momentum, with a 1 day share price return of 1.09% and a 7 day return of 3.75%. The 3 year total shareholder return of 49.46% and 5 year total shareholder...

VSE stock snapshot after recent moves VSE (VSEC) has drawn fresh attention after recent price swings, with the stock last closing at $177.43 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for VSE. The recent 5.54% 1 day share price return sits against a weaker 30 day and 90 day share price performance, while multi year total shareholder returns above 280% point to strong long term compounding. If VSE's recent volatility has you comparing...

If you are wondering whether Lennar’s current share price reflects its real worth, you are not alone. This article focuses on what the numbers say about value rather than short term market noise. The stock recently closed at US$86.20, with returns of a 6.6% decline over 7 days, a 0.3% decline over 30 days, a 17.3% decline year to date and a 17.3% decline over 1 year, putting recent price moves firmly on investors’ radar. Recent coverage has highlighted Lennar in the context of broader...

Recently, Alluvium announced a collaboration with Adobe to integrate Adobe Experience Platform into healthcare capacity management, while Adobe also finalized its acquisition of Semrush and filed a US$102.19 million employee stock offering shelf registration. Together with Adobe’s newly authorized US$25 billion share repurchase program, these moves highlight the company’s willingness to invest heavily in AI-driven growth while actively returning capital to shareholders. We’ll now examine how...

Celebrations may be in order for Sterling Infrastructure, Inc. ( NASDAQ:STRL ) shareholders, with the analysts...

If you are wondering whether Crown Castle stock is priced attractively right now, the recent mix of short term gains and longer term weakness makes the valuation story especially interesting. The share price closed at US$89.10, with returns of 3.4% over 7 days and 5.1% over 30 days. Year to date the stock is up 0.5%, but down 12.3% over 1 year, 10.2% over 3 years and 38.1% over 5 years. Recent headlines have focused on Crown Castle's position within U.S. telecom infrastructure and how...

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...

Roblox (NYSE:RBLX) has appointed Sunil Rao as Managing Director for India. Rao is tasked with leading local strategy and supporting growth in one of Roblox's fastest expanding international markets. This is Roblox's first direct senior leadership hire in India, focused on expanding the creator ecosystem and user base. Roblox runs a user generated content gaming and social platform where players and creators interact through virtual worlds. As global gaming, social interaction and digital...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Unsurprisingly, Seagate Technology Holdings plc's ( NASDAQ:STX ) stock price was strong on the back of its healthy...

Investors in Encompass Health Corporation ( NYSE:EHC ) had a good week, as its shares rose 3.4% to close at US$105...

Shareholders might have noticed that Shenandoah Telecommunications Company ( NASDAQ:SHEN ) filed its first-quarter...

Investors who take an interest in Option Care Health, Inc. ( NASDAQ:OPCH ) should definitely note that the Executive VP...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

As you might know, Solaris Energy Infrastructure, Inc. ( NYSE:SEI ) just kicked off its latest quarterly results with...

Collegium Pharmaceutical, a specialty pain-medicine maker, is approaching its first-quarter 2026 earnings release on May 7, with Wall Street expecting earnings per share of US$1.52 amid recent downward estimate revisions. Investors are increasingly focused on the company’s shrinking adjusted operating margin and relatively small revenue base, which together raise questions about the durability of future profits. We’ll now examine how concerns about Collegium’s weakening operating margin...

Pitney Bowes (PBI) has drawn fresh attention after first quarter 2026 earnings showed revenue of US$477.41 million, lower than a year earlier, alongside higher net income and raised full year revenue guidance. See our latest analysis for Pitney Bowes. The earnings release appears to have been a key catalyst, with the stock’s 30-day share price return of 40.89% and year to date share price return of 50.44% building on a very large 3-year total shareholder return. However, the 7-day share price...

New Jersey Resources (NJR) has just reported its Q2 2026 results, with Q1 fiscal 2026 revenue at US$604.9 million and EPS of US$1.22 setting the tone for how the year is shaping up for the utility. Over the past few quarters, revenue has ranged from US$298.9 million to US$913.0 million while EPS has moved between a loss of US$0.15 and a high of US$2.04. This gives a clear sense of how earnings and the top line have tracked across different periods. With trailing net margin at 15.2% and the...

In late April 2026, Southwest Airlines began offering discounted fares and A-List status matches to travelers stranded by Spirit Airlines’ shutdown, while also concluding a long-running legal dispute by paying US$946,102.87 in damages to former flight attendant Charlene Carter. This combination of opportunistic customer outreach to Spirit passengers and the resolution of a nearly decade-long legal case could influence how investors weigh Southwest’s growth opportunities against its legal and...

Moelis & Company recently reported first-quarter 2026 net income of US$38.43 million, down from US$50.27 million a year earlier, while also confirming a quarterly dividend of US$0.65 per share payable on June 18, 2026. Alongside these results, Moelis completed two share repurchase tranches totaling nearly US$53.64 million and filed a US$38.70 million employee stock ownership plan-related shelf registration for Class A common stock, highlighting an active approach to capital returns and...

Wondering if MGM Resorts International at around US$37.91 is a bargain or already pricing in the story? This article walks through what the current valuation signals might mean for you. The stock is up 20.7% over the last year, with returns of 3.9% year to date and 3.4% over the last month. However, the most recent week saw a 4.6% decline. Recent headlines around MGM Resorts International have focused on the company as a key player in US leisure and entertainment, with investors weighing how...

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...

Why Cytokinetics Stock Is Back on Investors’ Radar Cytokinetics (CYTK) has climbed recently, with the stock up 16.7% over the past day and 27% over the past week, prompting investors to reassess what is currently priced into this biopharmaceutical story. See our latest analysis for Cytokinetics. Today’s share price of $77.09 sits against a 1-year total shareholder return of 126.9% and a 5-year total shareholder return of about 3.2x. Recent double digit share price gains suggest momentum has...